• Profile
Close

Preperitoneal bupivacaine infiltration reduces postoperative opioid consumption, acute pain, and chronic postsurgical pain after bariatric surgery: A randomized controlled trial

Obesity Surgery Jun 26, 2018

Boerboom SL, et al. - Whether or not preperitoneal anesthesia with bupivacaine would reduce pain and opioid consumption after bariatric surgery was investigated. Preperitoneal bupivacaine 0.5% or normal saline was administered to 100 adults undergoing laparoscopic bariatric surgery before incision. Outcomes suggested a reduction in opioid consumption and postoperative pain in association with preperitoneal local anesthesia with bupivacaine. Hence, it seems to lower the incidence rate of chronic postsurgical pain after laparoscopic bariatric surgery.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay